Christopher R. Cline, CHIEF FINANCIAL OFFICER at Travere Therapeutics, Inc. (TVTX), sold 642 shares at $66.37 ($43K) on 2026-09-02, disclosed to the SEC on 2026-09-03.
Seasonal sale ($43k) by CHIEF FINANCIAL OFFICER — this insider has traded TVTX in September in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| TVTX | SELL | 2026-04-15 | $349K | — | Filing → |
| TVTX | SELL | 2026-02-05 | $56K | — | Filing → |
| TVTX | SELL | 2026-02-03 | $233K | — | Filing → |